Pfizer's Geodon Schizophrenia Drug On 500 Hospital, 46 Medicaid Formularies
Executive Summary
Pfizer's Geodon for schizophrenia has been added to more than 500 hospital formularies since its March launch, Pharmaceuticals Group President Karen Katen said during an April 18 analysts conference call.
You may also be interested in...
BI/Pfizer’s Spiriva Shows Bronchodilator Effect, Not Dyspnea, Cmte. Says
Boehringer Ingelheim/Pfizer's Spiriva demonstrates a clinically meaningful bronchodilator effect when used to treat chronic COPD patients, FDA's Pulmonary-Allergy Drugs Advisory Committee unanimously agreed Sept. 6
BI/Pfizer’s Spiriva Shows Bronchodilator Effect, Not Dyspnea, Cmte. Says
Boehringer Ingelheim/Pfizer's Spiriva demonstrates a clinically meaningful bronchodilator effect when used to treat chronic COPD patients, FDA's Pulmonary-Allergy Drugs Advisory Committee unanimously agreed Sept. 6
Pfizer/Pharmacia Bextra Will Be Premium Priced, In Pharmacies Feb. 15
Pharmacia/Pfizer's COX-2 inhibitor Bextra will be launched at a 10% price premium over Celebrex and Vioxx